comparemela.com
Home
Live Updates
Lynn Malec, MD: Efanesoctocog alfa Reduces Bleeds, Treatment Burden for Hemophilia : comparemela.com
Lynn Malec, MD: Efanesoctocog alfa Reduces Bleeds, Treatment Burden for Hemophilia
Efanesoctocog alfa demonstrates promising results in new phase 3 data emphasizing the drug's potential to address unmet needs within the hemophilia community.
Related Keywords
,
Lynn Malec
,
College Of Wisconsin
,
Drug Administration
,
Versiti Blood Research Institute
,
International Society On Thrombosis
,
International Society
,
Comprehensive Center
,
Bleeding Disorders
,
Medical College
,
Breakthrough Therapy
,
comparemela.com © 2020. All Rights Reserved.